Back to Search Start Over

Preoperative MRI features associated with lymphovascular invasion in node-negative invasive breast cancer: A propensity-matched analysis

Authors :
Hyejin, Cheon
Hye Jung, Kim
So Mi, Lee
Seung Hyun, Cho
Kyung Min, Shin
Gab Chul, Kim
Ji Young, Park
Won Hwa, Kim
Source :
Journal of magnetic resonance imaging : JMRI. 46(4)
Publication Year :
2016

Abstract

In node-negative disease, the presence of lymphovascular invasion (LVI) is reported to be an unfavorable prognostic factor. Thus, the aim of this study was to evaluate whether preoperative breast MRI features are associated with LVI in patients with node-negative invasive breast cancer by a propensity-matched analysis.Among 389 patients with node-negative invasive ductal breast cancer who had preoperative breast 3.0 Tesla MRI with precontrast T2-weighted fat-suppressed, pre- and dynamic postcontrast T1-weighted fat-suppressed sequences, 61 patients with LVI (LVI group) were matched with 183 patients without LVI (no LVI group) at a ratio of 1:3 in terms of age, histologic grade, tumor size, and hormone receptor status. Two radiologists reviewed the MRI features, following profiles of focal breast edema (peritumoral, prepectoral, subcutaneous), intratumoral T2 signal intensity, adjacent vessel sign, and increased ipsilateral whole-breast vascularity, in addition to 2013 Breast Imaging Reporting and Data System lexicon.The presence of peritumoral edema (45.9% [28/61] versus 30.6% [56/183], P = 0.030) and adjacent vessel sign (82.0% [50/61] versus 68.3% [125/183], P = 0.041) was significantly associated with LVI. Prepectoral edema was also more frequently observed in the LVI group than in the no LVI group with borderline significance (26.2% [16/61] versus 15.3% [28/183], P = 0.055). In cases of nonmass enhancement, regional enhancement was more frequently found in the LVI group than in the no LVI group (60.0% [3/4] versus 5.9% [1/4], P = 0.042).Preoperative breast MRI features may be associated with LVI in patients with node-negative invasive breast cancer.3 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2017;46:1037-1044.

Details

ISSN :
15222586 and 10371044
Volume :
46
Issue :
4
Database :
OpenAIRE
Journal :
Journal of magnetic resonance imaging : JMRI
Accession number :
edsair.pmid..........3d5b44690dc530ab10a82916bb24ed14